BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Anticancer prodrugs
,
Tamoxifen
,
rs2300478
,
FGF21
,
cell-cell adhesion
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lam cells
Summary
General Info
Curated Studies
Most Correlated Studies
Rapamycin-insensitive up-regulation of MMP2 and other genes in TSC2- deficient LAM-like cells
Analysis of spindle versus non-spindle morphology breast cancer cell lines
Cooperative Signaling in the STAT3 and NF-kB Pathways in Subtypes of diffuse large B cell lymphoma
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - T-ALL Jurkat cells with shRNA-mediated gene knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAI…
Liposomal delivery of lipoarabinomannan triggers Mycobacterium tuberculosis specific T-cells.
Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation.
Exposure of Monocytes to Lipoarabinomannan Promotes Their Differentiation into Functionally and Phen…
A single-stranded DNA aptamer against mannose-capped lipoarabinomannan enhances anti-tuberculosis ac…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-…
Doxycycline In Lymphangioleiomyomatosis (LAM)
Characterizing LAM With 11C-Choline PET/CT
A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ